Absolut: high spirits and high potential

Scope for growth in Absolut's core US market is limited - most of this year's US growth was driven by superpremium and flavored variants. It is, however, showing strong growth in the rest of the world. Absolut needs to keep its image fresh in the US to avoid sales decline, while promoting itself more heavily in Europe and Asia.

Published By Datamonitor

Absolute Systems offers a payment switch for deposits in South Africa

Absolute Systems, a South African ATM software developer, has launched Imali, a payment switch for secure deposits, consisting of a switch and a strongbox for use in secure environments to which small retailers have access. The attractions of the Imali service are security, since the cash becomes the responsibility of the bank once it is in the strongbox, and also its real-time capability.

Published By Datamonitor

ABSs provide opportunities for insurers

ABSs could provide an opportunity for insurers to improve their income streams and profitability, which are likely to suffer due to the justice secretary banning solicitor referral fees from April 2013.

Published By Datamonitor

Abu Dhabi moves towards generic prescribing

Earlier this year, the Health Authority of Abu Dhabi made an unprecedented move towards encouraging the use of generic drugs by forcing doctors throughout the emirate of Abu Dhabi to prescribe by molecular name. However, while intended to boost generic uptake, the law may simply see the decision to prescribe expensive branded drugs taken from doctors and given to pharmacists.

Published By Datamonitor

Acadia: a novel insomnia treatment is stirring

Results from a recent clinical trial have demonstrated that Acadia's ACP-103 improves quality of sleep by increasing slow wave sleep. This suggests that ACP-103 has potential as a novel treatment for sleep maintenance insomnia. However, more trials with larger patient samples are needed and the drug candidate has many hurdles to overcome before it can claim a place in the crowded insomnia market.

Published By Datamonitor

Acambis: leading the pack on West Nile fever vaccine

Concern is rising in parts of the US that a West Nile fever outbreak could cause an epidemic worse than that experienced in 2004, due to a wet spring and diminishing immunity in the bird population. The increasing impact of the West Nile Virus since its arrival in the US in 2000 highlights the need for a preventative vaccine, with Acambis [ACM.L] leading the race to bring one to market.

Published By Datamonitor

Accentia: uncertain role for SinuNase

Accentia believes that it has evidence to support a theory that most, if not all, cases of chronic sinusitis are caused by fungal-induced inflammation. Preliminary analysis of samples taken as part of a Phase III trial for one of the company's developmental compounds suggest a link, but the role of the drug in disease management is less clear.

Published By Datamonitor

Accenture/BioQ: promising alliance announced

Published By Datamonitor

Accessories still a must-have market

Accessories are less price sensitive than clothing, occupy less square footage and so offer a higher sales density. It is therefore unsurprising that the sector is becoming increasingly competitive as a growing number of retailers look to make their mark. A new report from Verdict Research explains how retailers can maximize their presence in the UK fashion accessories market...

Published By Datamonitor

Account aggregation: 61% of eFS customers will take advantage

Published By Datamonitor